683 related articles for article (PubMed ID: 26819502)
21. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
[TBL] [Abstract][Full Text] [Related]
22. Probiotics and irritable bowel syndrome.
Dai C; Zheng CQ; Jiang M; Ma XY; Jiang LJ
World J Gastroenterol; 2013 Sep; 19(36):5973-80. PubMed ID: 24106397
[TBL] [Abstract][Full Text] [Related]
23. Microbiome and Its Role in Irritable Bowel Syndrome.
Pimentel M; Lembo A
Dig Dis Sci; 2020 Mar; 65(3):829-839. PubMed ID: 32026278
[TBL] [Abstract][Full Text] [Related]
24. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Posserud I; Stotzer PO; Björnsson ES; Abrahamsson H; Simrén M
Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
[TBL] [Abstract][Full Text] [Related]
25. Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.
Ghoshal UC; Srivastava D
World J Gastroenterol; 2014 Mar; 20(10):2482-91. PubMed ID: 24627585
[TBL] [Abstract][Full Text] [Related]
26. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence.
Quigley EM
J Clin Gastroenterol; 2015; 49 Suppl 1():S60-4. PubMed ID: 26447967
[TBL] [Abstract][Full Text] [Related]
27. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
Moraru IG; Moraru AG; Andrei M; Iordache T; Drug V; Diculescu M; Portincasa P; Dumitrascu DL
Rom J Intern Med; 2014; 52(3):143-50. PubMed ID: 25509557
[TBL] [Abstract][Full Text] [Related]
28. Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
Aziz I; Törnblom H; Simrén M
Curr Opin Gastroenterol; 2017 May; 33(3):196-202. PubMed ID: 28257307
[TBL] [Abstract][Full Text] [Related]
29. Dysbiosis in Irritable Bowel Syndrome.
Abraham P; Pratap N
J Assoc Physicians India; 2023 Sep; 71(9):75-81. PubMed ID: 38700306
[TBL] [Abstract][Full Text] [Related]
30. Intestinal microbiota and its role in irritable bowel syndrome (IBS).
Ohman L; Simrén M
Curr Gastroenterol Rep; 2013 May; 15(5):323. PubMed ID: 23580243
[TBL] [Abstract][Full Text] [Related]
31. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly
Wu KQ; Sun WJ; Li N; Chen YQ; Wei YL; Chen DF
Scand J Gastroenterol; 2019 Dec; 54(12):1419-1425. PubMed ID: 31765575
[No Abstract] [Full Text] [Related]
32. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
Singh P; Lembo A
Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
[TBL] [Abstract][Full Text] [Related]
33. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review.
Schmulson M; Bielsa MV; Carmona-Sánchez R; Hernández A; López-Colombo A; López Vidal Y; Peláez-Luna M; Remes-Troche JM; Tamayo JL; Valdovinos MA
Rev Gastroenterol Mex; 2014; 79(2):96-134. PubMed ID: 24857420
[TBL] [Abstract][Full Text] [Related]
34. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
[TBL] [Abstract][Full Text] [Related]
35. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions.
Hyland NP; Quigley EM; Brint E
World J Gastroenterol; 2014 Jul; 20(27):8859-66. PubMed ID: 25083059
[TBL] [Abstract][Full Text] [Related]
36. Irritable bowel syndrome: a concise review of current treatment concepts.
Wall GC; Bryant GA; Bottenberg MM; Maki ED; Miesner AR
World J Gastroenterol; 2014 Jul; 20(27):8796-806. PubMed ID: 25083054
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
Konturek PC; Zopf Y
MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulation of enteric neural function in irritable bowel syndrome.
O'Malley D
World J Gastroenterol; 2015 Jun; 21(24):7362-6. PubMed ID: 26139983
[TBL] [Abstract][Full Text] [Related]
39. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.
Spiegel BM
Clin Gastroenterol Hepatol; 2011 Jun; 9(6):461-9; quiz e59. PubMed ID: 21397724
[TBL] [Abstract][Full Text] [Related]
40. Manipulation of the Microbiota Using Probiotics.
Grimm V; Riedel CU
Adv Exp Med Biol; 2016; 902():109-17. PubMed ID: 27161354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
